Pyridines were reported to possess anticonvulsant, 1,2) cardiotonic, 3) antihypertensive, 4) b-adrenergic blocking activity.
1
H-NMR spectra were recorded on 300 MHz Bruker DPX 200. The chemical shifts are reported as parts per million downfield from tetra methyl silane (Me 4 Si). Microanalyses for C, H, N were performed in Heraeus CHN Rapid Analyzer. Analyses indicated by the symbols of the elements are within Ϯ0.4% of the theoretical values.
1 H-NMR and IR spectra were consistent with the assigned structures. Synthesis of 2-(2-Chloroethylamino)-6-aminopyridine 2,6-Diaminopyridine was reacted with 1,2-dichloroethane, using the previously reported procedure. 10) A solution of sodium methoxide (0.113 mol of sodium and 75 ml of methanol) was added to 0.113 mol of 2,6-diaminopyridine and refluxed for 1 h. Then the methanol was completely removed from the medium and 10 ml of anhydrous dimethyl formamide (DMF) was added to the dry residue. A solution of 1,2-dichloroethane (0.113 mol) in 10 ml anhydrous dimethyl formamide was then added dropwise to the reaction mixture with continuous stirring. The mixture was stirred for 1 h at room temperature. The product was filtered, dried in vacuum and recrystallised by using chloroform-diethylether (1 : 1). Yieldϭ56%, mp 175°C. General Method of Synthesis of 1a to m 2-(2-Chloroethylamino)-6-aminopyridine was reacted with various amines, using the previously reported procedure. 10) A solution of 2-(2-chloroethylamino)-6-aminopyridine (0.013 mol) and the appropriate amine (0.013 mol) in 40 ml of methanol was refluxed for 24 h. The product obtained was filtered, vacuum dried and recrystallized using 1 : 1 acetone-diethylether (1c, 1e, 1f, 1l), 1 : 1 ethanol-diethylether (1a, 1h, 1k, 1m), 1 : 1 chloroform-diethylether (1b, 1g) and 1 : 1 methanol-diethylether (1d, 1i, 1j).
2-(2-Morpholinoethylamino)-6-aminopyridine 1a: Yieldϭ45%, mp 250°C. Synthesis of 2-(2,3-Epoxypropylamino)-6-aminopyridine A solution of sodium methoxide (0.113 mol of sodium and 75 ml of methanol) was added to 0.113 mol of 2,6-diaminopyridine and refluxed for 1 h. Then the methanol was completely removed from the medium and 10 ml of anhydrous dimethyl formamide (DMF) was added to the dry residue. A solution of epichlorohydrin (0.113 mol) in 10 ml anhydrous dimethyl formamide was then added dropwise to the reaction mixture with continuous stirring. The mixture was stirred for 1 h at room temperature. The product was filtered, dried in vacuum and recrystallised by using ethanol-diethylether (1 : 1 General Method of Synthesis of 2a to j A solution of 2-(2,3-epoxypropylamino)-6-aminopyridine (0.013 mol) and the appropriate amine (0.013 mol) in 40 ml of methanol was refluxed for 24 h. The product obtained was filtered, vacuum dried and recrystallized using 1 : 1 acetone-diethylether (2b, 2d, 2j), 1 : 1 ethanol-diethylether (2c, 2f, 2g, 2i), 1 : 1 chloroform-diethylether (2a) and 1 : 1 methanol-diethylether (2e, 2h).
2-(2-Hydroxy-3-morpholinopropylamino)-6-aminopyridine 2a: Yieldϭ 29%, mp Ͼ300°C. Synthesis of 2-(2-Chloroethylamino)-6-methylpyridine A solution of sodium methoxide (0.113 mol of sodium and 75 ml of methanol) was added to 0.113 mol of 2-amino-6-methylpyridine and refluxed for 1 h. Then the methanol was completely removed from the medium and 10 ml of anhydrous dimethyl formamide (DMF) was added to the dry residue. A solution of 1,2-dichloroethane (0.113 mol) in 10 ml anhydrous dimethyl formamide was then added dropwise to the reaction mixture with continuous stirring. The mixture was stirred for 1 h at room temperature. The product was filtered, dried in vacuum and recrystallised by using chloroform-diethylether (1 : 1 General Method of Synthesis of 3a to j A solution of 2-(2-chloroethylamino)-6-methylpyridine (0.013 mol) and the appropriate amine (0.013 mol) in 40 ml of methanol was refluxed for 24 h. The product obtained was filtered, vacuum dried and recrystallized using 1 : 1 acetone-diethylether (3a, 3d, 3g), 1 : 1 ethanol-diethylether (3c, 3e, 3i), 1 : 1 chloroform-diethylether (3b, 3j) and 1 : 1 methanol-diethylether (3f, 3h).
2-(2-Morpholinoethylamino)-6-methylpyridine 3a: Yieldϭ45%, mp Ͼ300°C. Synthesis of 2-(2,3-Epoxypropylamino)-6-methylpyridine A solution of sodium methoxide (0.113 mol of sodium and 75 ml of methanol) was added to 0.113 mol of 2-amino-6-methylpyridine and refluxed for 1 h. Then the methanol was completely removed from the medium and 10 ml of anhydrous dimethyl formamide (DMF) was added to the dry residue. A solution of epichlorohydrin (0.113 mol) in 10 ml anhydrous dimethyl formamide was then added dropwise to the reaction mixture with continuous stirring. The mixture was stirred for 1 h at room temperature. The product was filtered, dried in vacuum and recrystallised by using ethanol-diethylether (1 : 1 General Method of Synthesis of 4a to j A solution of 2-(2,3-epoxypropylamino)-6-methylpyridine (0.013 mol) and the appropriate amine (0.013 mol) in 40 ml of methanol was refluxed for 24 h. The product obtained was filtered, vacuum dried and recrystallized using 1 : 1 acetone-diethylether (4a, 4f, 4h), 1 : 1 ethanol-diethylether (4d, 4e, 4g, 4j), 1 : 1 chloroform-diethylether (4b) and 1 : 1 methanol-diethylether (4c, 4i).
2-(2-Hydroxy-3-morpholinopropylamino)-6-methylpyridine 4a: Yieldϭ 29%, mp 248-249°C. 
Pharmacology
All the synthesized compounds were screened for anticonvulsant activity. The amphetamine antagonism was done at the dose of 25 mg and 50 mg/kg. The experimental dose for the amphetamine antagonism was selected between the minimal effective and maximal non-lethal dose. The compounds were also screened for the cardiac activity on isolated frog heart. All the compounds were soluble in water and administered to the animals as a solution in water for injection and triple glass distilled water. Wistar albino mice (18-25 g) and hartely guinea pig of either sex were procured from King Institute, Guindy, Chennai. They were kept in colony cages at 25Ϯ2°C, relative humidity 45-55% under 12 h light and dark cycle (0600 to 1800 h-light; 1800 to 0600 h-dark). All the animals were acclimatized for a week before use. Small frogs (Rana trigana, 80-120 g) were procured locally and used on the same day. Unpaired Student t-test 14) was performed to ascertain the significance of the exhibited activity.
Anticonvulsant activity The compounds were tested for anticonvulsant activity by using the procedures described previously. 15, 16) All compounds were tested for anticonvulsant activity with wistar albino mice (nϭ5). Each compound was administered intraperitoneally at three dose levels (30, 100, 300 mg/kg). Three tests were performed for each compound; maximal electroshock (MES) induced convulsions, subcutaneous Metrozol (sc-Met) induced convulsions and rotarod neurotoxicity test (Tox). The compounds were made solution with water for injection.
Maximal electroshock seizures (MES) were induced 30 min after drug treatment by application of 50 mA current for 0.2 s via corneal electrodes into the eyes. The protection was defined as the abolition of hind leg and tonic maximal extension component of the seizure. The subcutaneous pentylenetetrazole (Metrozol) seizure threshold test (sc-Met) was carried out by the subcutaneous administration of pentylenetetrazole (85 mg/kg). Animals were observed for over 30 min. Failure to observe the generalised clonic seizure is defined as protection. Minimal neurotoxicity (TD 50 ) was measured by the rotarod test (Tox). Wistar albino mice (nϭ4) were placed in 1-in. diameter knurled plastic rod rotating 6 rpm after administration of the drug, and their ability to maintain their balance was tested. Neurological deficit was indicated by the inability of the animal to maintain the equilibrium for 1 min on the rotating rod in each of three trials. The results are tabulated in Ta- Amphetamine Antagonistic Activity The decrease in the motor activity 17) induced by introceptine stimuli of the compounds was studied by amphetamine antagonism. Wistar albino mice (nϭ6) of either sex were selected by random sampling technique. The compounds were administered at a dose level 25 mg and 50 mg/kg, i.p. 30 min prior to the administration of amphetamine (5 mg/kg, i.p.). Phenobarbital (10 mg/kg, i.p.) was used as the standard drug. The motor activity of the animals (groupwise) was observed for 15 min in an octophotometer after 10 min of amphetamine administration. 70% decrease in motor activity is defined as significant decrease in motor activity. The percentage reduction of motor activity by the compounds are presented in Table 3 .
Cardiac Activity 18) Isolated frog heart was mounted using normal amphibian ringer solution. The effect of the compounds on the rate and force of contraction was observed from 1 to 400 mg/animal. The effect of the compounds at various concentration with simultaneous administration of adrenaline (100, 200, 400 mg/dose) was also studied ( Table  4) .
Evaluation of Antihistaminic Activity 19) The terminal portion of the guinea pig ileum was dissected out from overnight fasted (water given ad libitum) healthy hartely strain of guinea pigs. Antihistaminic activity based on the antagonism to the contraction of smooth muscle and the capillary dilation produced by histamine. The ileum was mounted by using tyrode solution bubbled with O 2 (95%) and CO 2 (5%) mixture at 37Ϯ0.5°C. The effect of the compounds (250, 500, 1000 mg/dose) on histamine-induced contractions was reported in Table 5 .
Results and Discussion
The initial evaluation (phase I) of anticonvulsant activity of synthesized compounds were presented in the 1d and 1g were found to have high degree of protection against MES-induced seizures. Only heterocyclic (piperazino and imidazolo) groups substituted at the 2nd position showed more protection than the other substitution. In the ethane series of 6-methyl (3a-j), compounds 3c, 3d, 3f and 3i were found to have high degree of protection against MES-induced seizures. Piperazino and imidazolo groups substituted at the 2nd position showed more protection than the other substitutions. 4-Hydroxyphenylamino substituted compound is more active among all the substitutions. b-Blockers and aryloxypropanolamines 20) inhibit adenylyl cyclase, which reduces the production of c-AMP (adenosine mono phosphate). c-AMP activates the phosphorylation of hydroxyl group containing aminoacids such as tyrosine, ser-ine and threonine which causes the enzyme to change the shape, which causes the release of Ca 2ϩ . Since b-blockers reduce c-AMP, less Ca ions are released. The propanol series of compounds may be correlated to the presence of the pharmacophore similarity to the chemical functionality present in b-adrenergic blocking agents. It may be hypothesized that the anticonvulsant activity exerted by some of the compounds by blocking Ca 2ϩ channels. Calcium influx via voltage-activated Ca 2ϩ channels also plays a role in epileptogenesis and neurodegenerative events, raising the possibility that the blockade of Ca 2ϩ channels may represent the mechanism of action of these compounds.
1c, 1h, 1I, 2a, 2d, 2g, 2h, 3b, 3e, 3I, 3j, 4b, 4d, 4e, 4f, 4g and 4j compounds exhibited significant decrease (70%) motor activity.
With respect to the 6-amino derivatives, the decrease in motor activity by the compounds in ethane series (1a-m) was found to be in the order of 1hϾ1cϾ1i. Among the heterocyclic groups substituted at the 2nd position piperazino substituted compound is more active than piperidino and imidazolo substituted compounds. None of the tertiary amines showed promising activity, whereas secondary amine substituted at the 2nd position, (phenylamino) showed better activity. The decrease in motor activity by the compounds with respect to propanol series (2a-j) was found to be in the order of 2gϾ2dϾ2aϾ2h. Among the heterocyclic groups substituted at the 3rd position imidazolo substituted compound is more active than piperidino and piperazino substituted compounds. Among the tertiary amines diethanolamino compound showed promising activity, whereas secondary amine substituted at the 3rd position, phenylamino, showed better activity.
With respect to the 6-methyl derivatives, the decrease in motor activity by the compounds in ethane series (3a-j) was found to be in the order of 3eϾ3iϾ3bϾ3j. Among the heterocyclic groups substituted at the 2nd position piperidino substituted compound is more active than imidazolo and piperazino substituted compounds. Among the tertiary amines diethylamino compound showed promising activity, methylamino substituted at the 2nd position showed better activity than 4-hydroxyphenylamino among the secondary amines. The decrease in motor activity by the compounds with respect to propanol series (4a-j) was found to be in the order of 4dϾ4jϾ4f. Among the heterocyclic groups substituted at the 3rd position imidazolo substituted compound is more active than piperidino and piperazino substituted compounds. Among the tertiary amines diphenylamino compound showed promising activity, whereas secondary amine substituted at the 3rd position methylamino showed better activity.
2a , 2b, 2c, 2d, 2e, 2f, 2g, 2h, 2I, 2j, 4a, 4b, 4c, 4d , 4e, 4f, 4g and 4h exhibited potential cardiac activity. None of ethane series compounds found to be active. Among the propanol series piperazino substituted compound showed better blocking activity than the other heterocyclic compounds where as all other compounds are less active than piperazino substituted compound. Among the tertiary amines substituted amino compounds is more active than the other compounds. 4-hydroxyphenylamino is more active among secondary amines. Electron pumping groups have prominent role in this effect. Proton pumping groups significantly downplayed the effect of blocking adrenaline in the entire series. The cardiac activity exhibited by these compounds may be correlated to the presence of the pharmacophore similarity to the chemical functionality present in b-adrenergic blocking agents. When administered concurrently with adrenaline, the compounds exhibited significant sympatholytic action. The compounds were able to block the effects of adrenaline (100, 200, 400 mg).
In the antihistaminic activity, almost all the ethane derivatives showed promising activity, whereas propanol series of compounds found to be inactive. The active compounds were 1c, 1e, 1f, 1g, 3c, 3e, 3f, 3g and 3j. Diethanolamino and diethylamino substituted compounds found to be more active in the entire series. This promising activity may be because of similarity of the functionality with other antihistaminic agents.
